1-Jul-2026
Analysts’ Top Healthcare Picks: Harrow Health (HROW), Genmab (GMAB)
TipRanks (Tue, 30-Jun 7:50 AM ET)
Business Wire (Mon, 29-Jun 4:05 PM ET)
Market Chameleon (Tue, 12-May 3:34 AM ET)
PACS Group, Inc. Reports First Quarter 2026 Results
Business Wire (Mon, 11-May 4:30 PM ET)
Business Wire (Tue, 5-May 6:00 AM ET)
PACS Group Announces Acquisition in Alaska; New Construction of a Skilled Nursing Community
Business Wire (Fri, 1-May 2:16 PM ET)
PACS Group, Inc. Announces the Appointment of Carey P. Hendrickson as Chief Financial Officer
Business Wire (Mon, 27-Apr 4:35 PM ET)
PACS Group, Inc. Announces Retirement of Co-Founder and CFO Mark Hancock
Business Wire (Mon, 27-Apr 4:33 PM ET)
Globe Newswire (Tue, 21-Apr 8:00 AM ET)
Market Chameleon (Thu, 20-Nov 5:29 AM ET)
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
Pacs Group trades on the NYSE stock market under the symbol PACS.
As of July 1, 2026, PACS stock price climbed to $44.32 with 1,182,617 million shares trading.
PACS has a beta of -0.43, meaning it tends to be less sensitive to market movements. PACS has a correlation of 0.00 to the broad based SPY ETF.
PACS has a market cap of $7.01 billion. This is considered a Mid Cap stock.
Last quarter Pacs Group reported $1 billion in Revenue and $.50 earnings per share. This beat revenue expectation by $59 million and exceeded earnings estimates by $.09.
The top ETF exchange traded funds that PACS belongs to (by Net Assets): AVUV, IWM, VTI, VB, VBK.
PACS has outperformed the market in the last year with a price return of +242.2% while the SPY ETF gained +22.0%. PACS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +39.9% and +25.8%, respectively, while the SPY returned +14.1% and +1.2%, respectively.
PACS support price is $41.12 and resistance is $44.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PACS shares will trade within this expected range on the day.